PMID- 27919654
OWN - NLM
STAT- MEDLINE
DCOM- 20170802
LR  - 20220408
IS  - 1873-1449 (Electronic)
IS  - 1538-4721 (Linking)
VI  - 16
IP  - 1
DP  - 2017 Jan-Feb
TI  - American Brachytherapy Society: Brachytherapy treatment recommendations for 
      locally advanced cervix cancer for low-income and middle-income countries.
PG  - 85-94
LID - S1538-4721(16)30572-4 [pii]
LID - 10.1016/j.brachy.2016.10.007 [doi]
AB  - PURPOSE: Most cervix cancer cases occur in low-income and middle-income countries 
      (LMIC), and outcomes are suboptimal, even for early stage disease. Brachytherapy 
      plays a central role in the treatment paradigm, improving both local control and 
      overall survival. The American Brachytherapy Society (ABS) aims to provide 
      guidelines for brachytherapy delivery in resource-limited settings. METHODS AND 
      MATERIALS: A panel of clinicians and physicists with expertise in brachytherapy 
      administration in LMIC was convened. A survey was developed to identify practice 
      patterns at the authors' institutions and was also extended to participants of 
      the Cervix Cancer Research Network. The scientific literature was reviewed to 
      identify consensus papers or review articles with a focus on treatment of locally 
      advanced, unresected cervical cancer in LMIC. RESULTS: Of the 40 participants 
      invited to respond to the survey, 32 responded (response rate 80%). Participants 
      were practicing in 14 different countries including both high-income (China, 
      Singapore, Taiwan, United Kingdom, and United States) and low-income or 
      middle-income countries (Bangladesh, Botswana, Brazil, India, Malaysia, Pakistan, 
      Philippines, Thailand, and Vietnam). Recommendations for modifications to 
      existing ABS guidelines were reviewed by the panel members and are highlighted in 
      this article. CONCLUSIONS: Recommendations for treatment of locally advanced, 
      unresectable cervical cancer in LMIC are presented. The guidelines comment on 
      staging, external beam radiotherapy, use of concurrent chemotherapy, overall 
      treatment duration, use of anesthesia, applicator choice and placement 
      verification, brachytherapy treatment planning including dose and prescription 
      point, recommended reporting and documentation, physics support, and follow-up.
CI  - Copyright (c) 2016 American Brachytherapy Society. Published by Elsevier Inc. All 
      rights reserved.
FAU - Suneja, Gita
AU  - Suneja G
AD  - Duke University, Durham, NC. Electronic address: Gita.suneja@icloud.com.
FAU - Brown, Derek
AU  - Brown D
AD  - University of California San Diego, San Diego, CA.
FAU - Chang, Amy
AU  - Chang A
AD  - Pamela Youde Nethersole Eastern Hospital, Hong Kong.
FAU - Erickson, Beth
AU  - Erickson B
AD  - Medical College of Wisconsin, Milwaukee, WI.
FAU - Fidarova, Elena
AU  - Fidarova E
AD  - International Atomic Energy Agency, Vienna, Austria.
FAU - Grover, Surbhi
AU  - Grover S
AD  - University of Pennsylvania, Philadelphia, PA; Princess Marina Hospital, Gaborone, 
      Botswana.
FAU - Mahantshetty, Umesh
AU  - Mahantshetty U
AD  - Tata Memorial Center, Mumbai, India.
FAU - Nag, Subir
AU  - Nag S
AD  - Kaiser Permanente, Santa Clara, CA.
FAU - Narayan, Kailash
AU  - Narayan K
AD  - Peter MacCallum Cancer Centre, Melbourne, Australia.
FAU - Bvochora-Nsingo, Memory
AU  - Bvochora-Nsingo M
AD  - Gaborone Private Hospital, Gaborone, Botswana.
FAU - Viegas, Celia
AU  - Viegas C
AD  - Instituto Nacional de Cancer- INCA, Rio de Janeiro, Brazil.
FAU - Viswanathan, Akila N
AU  - Viswanathan AN
AD  - Johns Hopkins University, Baltimore, MD.
FAU - Lin, Ming Yin
AU  - Lin MY
AD  - Peter MacCallum Cancer Centre, Melbourne, Australia.
FAU - Gaffney, David
AU  - Gaffney D
AD  - University of Utah, Salt Lake City, UT.
LA  - eng
PT  - Journal Article
PT  - Practice Guideline
DEP - 20161203
PL  - United States
TA  - Brachytherapy
JT  - Brachytherapy
JID - 101137600
SB  - IM
MH  - Brachytherapy/*methods/standards
MH  - Developing Countries
MH  - Female
MH  - Health Resources
MH  - Humans
MH  - Radiation Oncology
MH  - Radiotherapy
MH  - Radiotherapy Dosage
MH  - Societies, Medical
MH  - United States
MH  - Uterine Cervical Neoplasms/pathology/*radiotherapy
OTO - NOTNLM
OT  - Brachytherapy
OT  - Cervix cancer
OT  - Consensus guidelines
OT  - Global oncology
OT  - Low-resource setting
EDAT- 2016/12/07 06:00
MHDA- 2017/08/03 06:00
CRDT- 2016/12/07 06:00
PHST- 2016/07/28 00:00 [received]
PHST- 2016/09/06 00:00 [revised]
PHST- 2016/10/21 00:00 [accepted]
PHST- 2016/12/07 06:00 [pubmed]
PHST- 2017/08/03 06:00 [medline]
PHST- 2016/12/07 06:00 [entrez]
AID - S1538-4721(16)30572-4 [pii]
AID - 10.1016/j.brachy.2016.10.007 [doi]
PST - ppublish
SO  - Brachytherapy. 2017 Jan-Feb;16(1):85-94. doi: 10.1016/j.brachy.2016.10.007. Epub 
      2016 Dec 3.